MobileODT raises $7m for portable cervical cancer detection device July 6, 2017 By Sarah Faulkner MobileODT said today that it raised $6.8 million in a Series B financing round. OrbiMed Advisors led the financing and was joined by a previous investor, Tristel. To date, the Israeli cancer diagnostic company has raised more than $13 million. Get the full story at our sister site, MassDevice.
Traditional echocardiograms could help measure cardiovascular stiffness, a potential breakthrough in precision heart care